Literature DB >> 24966614

Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation.

Wen Zhang1, Zhong-Yang Shen1, Hong-Li Song1, Yang Yang1, Ben-Juan Wu1, Nan-Nan Fu1, Tao Liu1.   

Abstract

AIM: To explore the protective effect of bone marrow mesenchymal stem cells (BM MSCs) in the small intestinal mucosal barrier following heterotopic intestinal transplantation (HIT) in a rat model.
METHODS: BM MSCs were isolated from male Lewis rats by density gradient centrifugation, cultured, and analyzed by flow cytometry. The HIT models were divided into a non-rejection group, saline-treated rejection group (via penile vein), and BM MSC-treated group (via penile vein). Intestinal mucosal barrier injury was estimated by diamine oxidase (DAO) and D-lactic acid (D-LA) expression levels. Tumor necrosis factor-α (TNF-α), interferon-γ (INF-γ), interleukin-10 (IL-10), and transforming growth factor-β (TGF-β) were detected by enzyme-linked immunosorbent assay. Ultrastructural change of tight junctions (TJs) was observed under transmission electron microscope. Expression levels of the TJ proteins occludin and zona occludens (ZO)-1, affected by the inflammatory factors, were measured using real-time polymerase chain reaction and Western blotting.
RESULTS: The pathological score at each time point after surgery indicated significantly less serious injury in the BM MSCs-treated group than in the rejection group (P < 0.05). In the former, graft levels of DAO and D-LA were reduced, and TNF-α and INF-γ production was inhibited (at day 7: 10.6473 ± 0.0710 vs 17.2128 ± 0.4991, P < 0.05; 545.1506 ± 31.9416 vs 810.2637 ± 25.1175, P < 0.05). IL-10 and TGF-β production was increased greatly (at day 7: 125.7773 ± 4.7719 vs 80.3756 ± 2.5866, P < 0.05; 234.5273 ± 9.3980 vs 545.1506 ± 31.9416, P < 0.05). There was increased expression of occludin and ZO-1 protein (at day 7: 0.2674 ± 0.0128 vs 0.1352 ± 0.0142, P < 0.05; at day 5: 0.7189 ± 0.0289 vs 0.4556 ± 0.0242, P < 0.05) and mRNA (at day 7: 0.3860 ± 0.0254 vs 0.1673 ± 0.0369, P < 0.05; at day 5: 0.5727 ± 0.0419 vs 0.3598 ± 0.0242, P < 0.05).
CONCLUSION: BM MSCs can improve intestinal barrier permeability, repair TJs, and increase occludin and ZO-1 protein expression. With altered cytokine levels, they can protect the intestinal mucosa after transplantation.

Entities:  

Keywords:  Bone marrow mesenchymal stem cells; Intestinal mucosal barrier; Occludin; Small intestinal transplantation; Zona occludens-1

Mesh:

Substances:

Year:  2014        PMID: 24966614      PMCID: PMC4064089          DOI: 10.3748/wjg.v20.i23.7442

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  In vitro neural differentiation of bone marrow stromal cells induced by cocultured olfactory ensheathing cells.

Authors:  Wen-Fei Ni; Li-Hui Yin; Jike Lu; Hua-Zi Xu; Yong-Long Chi; Jian-Bo Wu; Nu Zhang
Journal:  Neurosci Lett       Date:  2010-03-27       Impact factor: 3.046

Review 2.  The tight junction in inflammatory disease: communication breakdown.

Authors:  Karen L Edelblum; Jerrold R Turner
Journal:  Curr Opin Pharmacol       Date:  2009-07-24       Impact factor: 5.547

Review 3.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

4.  Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function.

Authors:  Taihei Ito; Shin Itakura; Ivan Todorov; Jeffrey Rawson; Sadaki Asari; Jonathan Shintaku; Indu Nair; Kevin Ferreri; Fouad Kandeel; Yoko Mullen
Journal:  Transplantation       Date:  2010-06-27       Impact factor: 4.939

5.  Hepatic differentiation of mesenchymal stem cells: in vitro strategies.

Authors:  Sarah Snykers; Joery De Kock; Vanhaecke Tamara; Vera Rogiers
Journal:  Methods Mol Biol       Date:  2011

6.  Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis.

Authors:  A Sémont; M Mouiseddine; A François; C Demarquay; N Mathieu; A Chapel; A Saché; D Thierry; P Laloi; P Gourmelon
Journal:  Cell Death Differ       Date:  2009-12-18       Impact factor: 15.828

7.  Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats.

Authors:  Haitao Jiang; Linlin Qu; Yun Li; Lili Gu; Yichao Shi; Jian Zhang; Weiming Zhu; Jieshou Li
Journal:  J Surg Res       Date:  2009-08-22       Impact factor: 2.192

8.  Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions.

Authors:  Bertha C Elias; Takuya Suzuki; Ankur Seth; Francesco Giorgianni; Gautam Kale; Le Shen; Jerrold R Turner; Anjaparavanda Naren; Dominic M Desiderio; Radhakrishna Rao
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

9.  Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.

Authors:  Yur-Ren Kuo; Shigeru Goto; Hsiang-Shun Shih; Feng-Sheng Wang; Chien-Chih Lin; Chun-Ting Wang; Eng-Yen Huang; Chao-Long Chen; Fu-Chan Wei; Xin Xiao Zheng; W P Andrew Lee
Journal:  Transplantation       Date:  2009-06-27       Impact factor: 4.939

Review 10.  Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential.

Authors:  Olga DelaRosa; Eleuterio Lombardo
Journal:  Mediators Inflamm       Date:  2010-06-14       Impact factor: 4.711

View more
  6 in total

Review 1.  Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Authors:  Dominique L Doster; Amanda R Jensen; Sina Khaneki; Troy A Markel
Journal:  Cytotherapy       Date:  2016-10-10       Impact factor: 5.414

2.  Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord.

Authors:  Peng Xia; Su Pan; Jieping Cheng; Maoguang Yang; Zhiping Qi; Tingting Hou; Xiaoyu Yang
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

3.  Ginsenoside Rb1 protects the intestinal mucosal barrier following peritoneal air exposure.

Authors:  Feng Zhou; Peichen Zhang; Xiaoxi Chen; Jingyi Yan; Jiangao Yao; Zhen Yu; Xiaolei Chen
Journal:  Exp Ther Med       Date:  2016-08-31       Impact factor: 2.447

4.  Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Authors:  Wei-Ping Zheng; Bo-Ya Zhang; Zhong-Yang Shen; Ming-Li Yin; Yi Cao; Hong-Li Song
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

5.  Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation.

Authors:  Liu Yang; Zhong-Yang Shen; Rao-Rao Wang; Ming-Li Yin; Wei-Ping Zheng; Bin Wu; Tao Liu; Hong-Li Song
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

6.  Comparing the gastrointestinal barrier function between growth-retarded and normal yaks on the Qinghai-Tibetan Plateau.

Authors:  Jian Ma; Ali Mujtaba Shah; Zhisheng Wang; Rui Hu; Huawei Zou; Xueying Wang; Guang Cao; Quanhui Peng; Bai Xue; Lizhi Wang; Suonan Zhao; Xiangying Kong
Journal:  PeerJ       Date:  2020-09-03       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.